College of Pharmacy, University of Houston, Health 2, Room 4048, 4349 Martin Luther King Boulevard, Houston, TX, 77204-5047, USA.
Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Int J Clin Pharm. 2024 Dec;46(6):1525-1535. doi: 10.1007/s11096-024-01786-y. Epub 2024 Aug 27.
Suboptimal adherence to direct oral anticoagulants (DOACs) among atrial fibrillation (AF) patients remains currently a major concern due to the increased risk of cardiac and thromboembolic events.
To identify longitudinal distinct trajectories of DOAC adherence and sociodemographic and clinical factors associated with each trajectory.
Patients with AF who were prescribed with DOAC from July 2016-December 2017 were identified among patients enrolled in the Medicare Advantage Plan. Patients were followed up for a year after the index date to calculate the monthly proportion of days covered (PDC). The monthly PDC was incorporated into the logistic group-based trajectory model to evaluate distinct patterns of adherence. A multinomial regression model was carried out to assess various predictors associated with each trajectory. Sub-group analysis was conducted among incident DOAC users.
Total of 1969 patients with AF, four distinct trajectories of adherence were selected: adherent 36.8%, gaps in adherence 9.3%, gradual decline in adherence 29.7%, and rapid decline in adherence 24.2%. Significant predictors associated with suboptimal adherence trajectories were age (75 years or older), gender (male vs female), low-income subsidy health plan, prevalent users, and presence of comorbidities. Among 933 incident users, three adherence trajectories were identified: adherent trajectory (31.8%), rapid decline in adherence (32.5%), and gradual decline in adherence (35.6%). The significant predictors among incident users were gender (male vs female), low-income subsidy health plan, HAS-BLED score ≥ 2, and presence of coronary artery disease.
Adherence to DOACs was suboptimal among the total population and incident users.
由于心脏和血栓栓塞事件风险增加,房颤(AF)患者服用直接口服抗凝剂(DOAC)的依从性不理想仍然是目前的主要关注点。
确定 DOAC 依从性的纵向不同轨迹以及与每个轨迹相关的社会人口统计学和临床因素。
从参加医疗保险优势计划的患者中确定了 2016 年 7 月至 2017 年 12 月期间开处方 DOAC 的 AF 患者。在索引日期后随访患者一年,以计算每月的覆盖天数比例(PDC)。将每月 PDC 纳入逻辑分组轨迹模型,以评估不同的依从性模式。进行多变量回归模型以评估与每个轨迹相关的各种预测因素。在新使用 DOAC 的患者中进行了亚组分析。
共纳入 1969 例 AF 患者,选择了 4 种不同的依从性轨迹:依从性高的 36.8%、依从性有缺口的 9.3%、依从性逐渐下降的 29.7%和依从性迅速下降的 24.2%。与依从性不理想轨迹相关的显著预测因素为年龄(75 岁或以上)、性别(男性与女性)、低收入补贴健康计划、现有使用者和合并症。在 933 例新发使用者中,确定了 3 种依从性轨迹:依从性轨迹(31.8%)、依从性迅速下降(32.5%)和依从性逐渐下降(35.6%)。新发使用者中的显著预测因素为性别(男性与女性)、低收入补贴健康计划、HAS-BLED 评分≥2 和存在冠状动脉疾病。
在总人群和新使用者中,DOAC 的依从性不理想。